Interleukin-12 is synthesized by mesangial cells and stimulates platelet-activating factor synthesis, cytoskeletal reorganization, and cell shape change

American Journal of Pathology

Volumn 154, Issue 2, 1999, Pages 623-632

  Bussolati, Benedetta ^b   Mariano, Filippo ^b   Biancone, Luigi ^b   Foà, Robert ^b   David, Salvatore ^b   Cambi, Vincenzo ^b   Camussi, Giovanni ^a  

^a Lab di Immunopatologia Renale   (Italy)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIUM LIPOPOLYSACCHARIDE; INTERLEUKIN 12; SUPEROXIDE; THROMBOCYTE ACTIVATING FACTOR; TUMOR NECROSIS FACTOR ALPHA;

ARTICLE; CELL SHAPE; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOSKELETON; HUMAN; HUMAN CELL; INFLAMMATION; MESANGIUM CELL; PRIORITY JOURNAL; THROMBOCYTE ACTIVATION;

EID: 0032936918     PISSN: 00029440     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9440(10)65307-2     Document Type: Article

References (49)

1. Schlondorff D: Role of mesangium in microcirculatory control. Blood Purif 1997, 15:228-231
2. Stockand JD, Sansom SC: Regulation of filtration rate by glomerular mesangial cells in health and diabetic renal disease. Am J Kidney Dis 1997, 29:971-981
3. Menè P, Simonson MS, Dunn MJ: Physiology of the mesangial cell. Physiol Rev 1989, 69:1347-1424
4. Mc Manus L, Woodard DS, Deavers SI, Pinckard RN: Biology of disease: PAF molecular heterogeneity, pathobiological implications. Lab Invest 1993, 69:639-650
5. Venable ME, Zimmerman GA, McIntyre TM, Prescott SM: Platelet-activating factor: a phospholipid autacoid with diverse actions. J Lipid Res 1993, 34:691-702
6. Barnes PJ, Page CP, Henson P: Platelet-activating factor and human disease. London, Blackwell Scientific, 1989
7. Schlondorff D, Satriano JA, Hagege J, Perez J, Baud LJ: Effect of platelet-activating factor and serum treated zymosan on prostaglandin-E2 synthesis, arachidonic acid release and contraction of cultured mesangial cells. J Clin Invest 1984, 73:1227-1231
8. Camussi G, Turello E, Tetta C, Bussolino F, Baglioni C: Tumor necrosis factor induces contraction of mesangial cells and alters their cytoskeleton. Kidney Int 1990, 38(Suppl 30):S2-S9
9. Lopez-Farrè A, Gomez-Garre D, Bernabeu F, Montanes I, Millas I, Lopez-Novoa JM: Renal effects and mesangial cells contraction induced by endothelin are mediated by PAF. Kidney Int 1991, 39:624-630
10. Camussi G: Potential role of platelet-activating factor in renal pathophysiology. Kidney Int 1986, 29:469-477
11. Bussolati B, Mariano F, Guarini A, Cambi V, Foà R, Piccoli G, Camussi G: Platelet-activating factor synthesized by IL-12-stimulated PMN and NK cells mediates chemotaxis. J Immunol 1998, 161:1493-1500
12. Trincheri G: Interleukin-12: a proinflammatory cytokine with immunoregulatory functions that bridge innate resistance and antigen-specific adaptive immunity. Annu Rev Immunol 1995, 13:251-276
13. Kobayashi M, Fitz L, Ryan M, Hewic RM, Clark SC, Chan S, Loudon R, Sherman F, Perussia B, Trincheri G: Identification and purification of natural killer cell stimulatory factor (NKSF), a cytokine with multiple biologic effects on human lymphocytes. J Exp Med 1989, 170:827-846
14. Gately MK, Wolitzky AG, Quinn PM, Chizzonite R: Regulation of human cytotolytic lymphocyte responses by interleukin-12. Cell Immunol 1992, 143:127-142
15. D'Andrea A, Rengaraju M, Valiante N, Chehimi J, Kubin M, Aste M, Chan S, Kobayashi M, Young D, Nickbarg E, Chizzonite R, Wolf SF, Trincheri G: Production of natural killer cell stimulatory factor (interleukin-12) by peripheral blood mononuclear cells. J Exp Med 1992, 176:1387-1398
16. Seder RA, Kelsall BL, Jankovic D: Differential roles for IL-12 in the maintenance of immune responses in infectious versus autoimmune disease. J Immunol 1996, 157:2745-2748
17. Ring GH, Lakkis FG: T lymphocyte-derived cytokines in experimental glomerulonephritis: testing the Th1/Th2 hypothesis. Nephrol Dial Transplant 1998, 13:1101-1103
18. Fan X, Oertly B, Wutrich RP: Up-regulation of tubular epithelial interleukin-12 in autoimmune MRL-Fas lrp mice with renal injury. Kidney Int 1997, 51:79-86
19. Gollob JA, Kawasaki H, Ritz J: Interferon-γ and interleukin-4 regulate T cell interleukin-12 responsiveness through the differential modulation of high-affinity interleukin-12 receptor expression. Eur J Immunol 1997, 27:647-652
20. Striker GE, Killen P, Farin FM Human glomerular cells in vitro: isolation and characterization. Transpl Proc 1980. 12(Suppl 1):88-99
21. Striker GE, Striker LJ. Glomerular cell culture Lab Invest 1985, 53: 122-131
22. Desai BD, Quinn PM, Woiitzky AG, Mongini A, Chizzonite R. Gately MK: IL-12 receptor. II. Distribution and regulation of receptor expression. J Immunol 1992, 148:3125-3132
23. Camussi G, Tetta C, Bussolino F, Baglioni C: Platelet-activating factor is inhibited by plasma α1-proteinase inhibitor or α1-antichymotrypsin and is stimulated by proteinases. J Exp Med 1988, 168:1293-1306
24. Camussi G, Bussolino F, Salvidio G, Baglioni C: Tumor necrosis factor/cachectin stimulates peritoneal macrophages, polymorphonuclear neutrophils, and vascular endothelial cells to synthesize and release platelet-activating factor. J Exp Med 1987, 166:1390-1404
25. Bligh EG, Dyer WJ: A rapid method of total lipid extraction and purification. Can J Biochem Physiol 1959, 37:911-917
26. Benveniste J, Le Couedic JP, Polonsky J, Tence M: Structural analysis of purified platelet-activating factor by lipases. Nature 1977, 269:170-174
27. Silvestro L, Da Col R, Scappaticci E, Libertucci D, Biancone L, Camussi G: Development of an HPLC-MS technique, with an ionspray interface, for the determination of PAF and lyso-PAF in biological samples. J Chromatogr 1993, 647:261-271
28. Heuer HO, Casals-Stenzel J, Muacevic G, Weber KH: Pharmacologic activity of bepafant (WEB2170), a new and selective tetrazepinoic antagonist of platelet-activating factor. J Pharmacol Exp Ther 1990. 225:962-968
29. Terashita Z, Tsushima S, Yoshioka S, Namoto H, Inada Y, Nishikawa K: CV 3988: a specific antagonist of platelet-activating factor (PAF-acether). Life Sci 1983, 32:1975-1982
30. Guthrie LA, Mc Phail LC, Henson PM, Johnston RB: Priming of neutrophils for enhanced release of oxygen metabolites by bacterial lipopolysaccharide. J Exp Med 1984, 160:1656-1671
31. Wulf E, Deboben A, Bautz FA, Faulstich H, Wieland T: Fluorescenct phallotoxin: a tool for the visualization of cellular actin. Proc Natl Acad Sci USA 1979, 76:4498-4502
32. Chizzonite R, Truitt T, Desai BB, Nunes P, Polanski FJ, Stern AS, Gately MK: IL-12 receptor. I Characterization of the receptor on phytohemagglutinin-activated human lymphoblasts. J Immunol 1992, 148:3117-3124
33. Neuwirth R, Singhal P, Satriano JA, Braquet P, Schlonoorff D: Effect of platelet activating factor antagonists on cultured rat mesangial cells. J Pharmacol Exp Ther 1987, 243:409-414
34. Rabinowich H, Herbeman RB, Whiteside TL Differential effects of IL-12 and IL-2 on expression and function of cellular adhesion molecules on purified human natural killer cells. Cell Immunol 1993, 152:481-498
35. Allavena P, Paganin C, Zhou D, Sozzani S, Mantovani A: Interleukin-12 is chemotactic for natural killer cells and stimulates their interaction with vascular endothelium. Blood 1994, 84:2261-2268
36. Leonard JP, Waldburger K, Golman SJ: Prevention of experimental autoimmune encephalomyelitis by antibodies against interleukin 12. J Exp Med 1995, 181:381-386
37. Trembleau S, Penna G, Bosi E, Mortara M, Gately K, Adorini L: Interleukin 12 administration induces T helper type 1 cells and accelerates autoimmune diabetes in NOD mice. J Exp Med 1995, 181: 817-821
38. + T cells exhibiting an unbalanced Th1-type T cell cytokine pattern: reversal with IL-10. J Immunol 1998, 160:3602-3609
39. Kalluri R, Danoff TM, Okada H, Neilson EG: Susceptibility to anti-glomerular basement membrane disease and Goodpasture syndrome is linked to MHC class II genes and the emergence of T cell-mediated immunity in mice. J Clin Invest 1997, 100:2263-2275
40. Coelho SN, Saleem S, Konieczny BT, Parekh KR, Baddoura FK, Lakkis FG: Immunologic determinants of susceptibility to experimental glomerulonephritis: role of cellular immunity. Kidney Int 1997, 51:646-652
41. Santiago ML, Fossati L, Jecquet C, Muller W, Izui R, Reminger L: Interleukin-4 protects against a genetically linked lupus-like autoimmune syndrome. J Exp Med 1997, 185:65-70
42. Argane Y, Riemann H, Bhardway RS, Schwarz A, Sawada Y, Yamada H, Luger TA, Kubin M, Trincheri G, Schwarz T: IL-12 is expressed and released by human keratinocytes and epidermoid carcinoma cell lines. J Immunol 1994, 153:5366-5372
43. Penny MJ, Boyd RA, Hall BM: Role of T cells in the mediation of Heymann nephritis. II. Identification of Th1 and cytotoxic cells in glomeruli. Kidney Int 1997, 51:1059-1068
44. Presky DH, Yang H, Minetti LJ, Chua AO, Nabavi N, Wu CY, Gately MK, Gubler U: A functional interleukin 12 receptor complex is composed of two β-type cytokine receptor subunits. Proc Natl Acad Sci USA 1996, 93:14002-14007
45. Wu CY, Warrier RR, Carvajal DM, Chua AO, Minetti LJ, Chizzonite R, Mongini PK, Stern AS, Gubler U, Presky DH, Gately MK: Biological function and distribution of human interleukin-12 receptor β chain. Eur J Immunol 1996, 26:345-350
46. Rogge L, Barberis-Maino L, Biffi M, Passerini N, Presky DH, Gubler U, Sinigaglia F: Selective expression of an interleukin-12 receptor component by human T helper 1 cells. J Exp Med 1997, 185:825-831
47. Gately MK, Renzetti LM, Magram J, Stern AS, Adorini L, Gubler U, Presky DH: The interleukin-12/interleukin-12-receptor system: role in normal and pathologic immune responses. Annu Rev Immunol 1998, 16:495-521
48. Chan SH, Perussia B, Gupta JW, Kobayashi M, Pospisil M, Young HA, Wolf SF, Young D, Clark SC, Trincheri G: Induction of INF-γ production by NK cells stimulatory factor (NKSF): characterization of the responder cells and synergy with other inducers. J Exp Med 1991, 173:869-879
49. Aste-Amezaga M, D'Andrea A, Kubin M, Trincheri G: Cooperation of natural killer cell stimulatory factor/interleukin-12 with other stimuli in the induction of cytokines and cytotoxic cell-associated molecules in human T and NK cells. Cell Immunol 1994, 156:480-492